ES8705871A1 - Un procedimiento para preparar un derivado de benzofurano - Google Patents
Un procedimiento para preparar un derivado de benzofuranoInfo
- Publication number
- ES8705871A1 ES8705871A1 ES550482A ES550482A ES8705871A1 ES 8705871 A1 ES8705871 A1 ES 8705871A1 ES 550482 A ES550482 A ES 550482A ES 550482 A ES550482 A ES 550482A ES 8705871 A1 ES8705871 A1 ES 8705871A1
- Authority
- ES
- Spain
- Prior art keywords
- same
- preparing
- pharmaceutical composition
- formula
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28080184 | 1984-12-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8705871A1 true ES8705871A1 (es) | 1987-05-16 |
| ES550482A0 ES550482A0 (es) | 1987-05-16 |
Family
ID=17630158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES550482A Expired ES8705871A1 (es) | 1984-12-29 | 1985-12-27 | Un procedimiento para preparar un derivado de benzofurano |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4666931A (enExample) |
| EP (1) | EP0187387B1 (enExample) |
| JP (1) | JPS62155269A (enExample) |
| AT (1) | ATE37544T1 (enExample) |
| CA (1) | CA1260947A (enExample) |
| DE (1) | DE3565262D1 (enExample) |
| ES (1) | ES8705871A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL83215A (en) * | 1986-07-23 | 1991-12-15 | Lilly Co Eli | Synthesis of bicyclic heteroaromatic sulfonyl chlorides |
| US5202339A (en) * | 1987-08-28 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| JP2764262B2 (ja) * | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
| US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| JPH01100164A (ja) * | 1987-10-12 | 1989-04-18 | Shionogi & Co Ltd | スルファモイル−２−ベンゾフランカルボン酸誘導体 |
| AU623676B2 (en) * | 1988-08-24 | 1992-05-21 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
| US5441984A (en) * | 1994-01-06 | 1995-08-15 | Eli Lilly And Company | Urea, thiourea and guanidine derivatives |
| HUP9903797A3 (en) * | 1995-12-05 | 2001-08-28 | Darwin Discovery Ltd Milton Ro | Benzofuran carboxamides and sulphonamides, their use for producing medicaments and such medicaments |
| CN100413859C (zh) | 1996-01-23 | 2008-08-27 | 盐野义制药株式会社 | 磺化的氨基酸衍生物及含有它的金属蛋白酶抑制剂 |
| CA2252537A1 (en) * | 1996-05-20 | 1997-11-27 | Darwin Discovery Limited | Benzofuran carboxamides and their therapeutic use |
| US20040043224A1 (en) * | 2002-08-30 | 2004-03-04 | Shmuel Sternberg | Enhanced hydrophobic membranes and methods for making such membranes |
| FR2958290B1 (fr) | 2010-03-30 | 2012-10-19 | Sanofi Aventis | Procede de preparation de derives de sulfonamido-benzofurane |
| FR2958291B1 (fr) | 2010-04-01 | 2013-07-05 | Sanofi Aventis | Procede de preparation de derives d'amino-benzofurane |
| HUP1000330A2 (en) | 2010-06-18 | 2011-12-28 | Sanofi Sa | Process for the preparation of dronedarone and the novel intermediates |
| KR101734868B1 (ko) | 2010-07-22 | 2017-05-12 | 후소 야쿠힝 고교 가부시끼가이샤 | 벤조푸라논 화합물 및 그것을 포함하는 의약 조성물 |
| HUP1100167A2 (en) | 2011-03-29 | 2012-11-28 | Sanofi Sa | Process for preparation of dronedarone by mesylation |
| HUP1100165A2 (en) | 2011-03-29 | 2012-12-28 | Sanofi Sa | Process for preparation of dronedarone by n-butylation |
| FR2983198B1 (fr) | 2011-11-29 | 2013-11-15 | Sanofi Sa | Procede de preparation de derives de 5-amino-benzoyl-benzofurane |
| EP2617718A1 (en) | 2012-01-20 | 2013-07-24 | Sanofi | Process for preparation of dronedarone by the use of dibutylaminopropanol reagent |
| WO2013121235A2 (en) | 2012-02-13 | 2013-08-22 | Sanofi | Process for preparation of dronedarone by removal of hydroxyl group |
| US9249119B2 (en) | 2012-02-14 | 2016-02-02 | Sanofi | Process for the preparation of dronedarone by oxidation of a sulphenyl group |
| WO2013124745A1 (en) | 2012-02-22 | 2013-08-29 | Sanofi | Process for preparation of dronedarone by oxidation of a hydroxyl group |
| WO2013178337A1 (en) | 2012-05-31 | 2013-12-05 | Sanofi | Process for preparation of dronedarone by grignard reaction |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2697719A (en) * | 1948-07-31 | 1954-12-21 | Upjohn Co | N-arylsulfonyl p-aminobenzoyl glutamates |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| DE3110009A1 (de) * | 1981-03-11 | 1982-09-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue benzofuran-derivate, ihre herstellung und verwendung |
| NZ201219A (en) * | 1981-07-28 | 1984-10-19 | Reckitt & Colmann Prod Ltd | Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions |
| US4544667A (en) * | 1984-02-09 | 1985-10-01 | Merck & Co., Inc. | 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure |
-
1985
- 1985-12-27 JP JP60298622A patent/JPS62155269A/ja active Granted
- 1985-12-27 CA CA000498703A patent/CA1260947A/en not_active Expired
- 1985-12-27 US US06/814,135 patent/US4666931A/en not_active Expired - Fee Related
- 1985-12-27 ES ES550482A patent/ES8705871A1/es not_active Expired
- 1985-12-28 EP EP85116638A patent/EP0187387B1/en not_active Expired
- 1985-12-28 DE DE8585116638T patent/DE3565262D1/de not_active Expired
- 1985-12-28 AT AT85116638T patent/ATE37544T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0584316B2 (enExample) | 1993-12-01 |
| JPS62155269A (ja) | 1987-07-10 |
| EP0187387A1 (en) | 1986-07-16 |
| EP0187387B1 (en) | 1988-09-28 |
| US4666931A (en) | 1987-05-19 |
| ATE37544T1 (de) | 1988-10-15 |
| DE3565262D1 (en) | 1988-11-03 |
| CA1260947A (en) | 1989-09-26 |
| ES550482A0 (es) | 1987-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8705871A1 (es) | Un procedimiento para preparar un derivado de benzofurano | |
| ES483767A1 (es) | Procedimiento para producir n-arilsulfonil-l-argininamidas | |
| KR840005718A (ko) | 오메프라졸 중간체의 제조방법 | |
| FI864527L (fi) | Tricyklofoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandning. | |
| KR870001142A (ko) | 페닐 에테르의 제법 | |
| ES8506612A1 (es) | Un metodo para producir un derivado de amina | |
| KR890002119A (ko) | 3-데메틸메발론산 유도체, 이의 제조방법, 이 화합물을 기본으로 하는 약제학적 조성물, 이의 용도 및 중간체 | |
| ES8401025A1 (es) | Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos. | |
| ES8603497A1 (es) | Procedimiento para preparar derivados de cefalosporina | |
| ES8606282A1 (es) | Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos | |
| ES8609204A1 (es) | Procedimiento de preparar derivados aminicos | |
| HUT34166A (en) | Process for producing of imidazol-ethanol esthers | |
| ES8801174A1 (es) | Un procedimiento para la preparacion de derivados de tetrahidronaftaleno. | |
| ES8307718A1 (es) | "procedimiento de preparar amidoaminoacidos y similares". | |
| ES8706148A1 (es) | Un procedimiento para preparar nuevos derivados de carbapenem. | |
| JPS56103168A (en) | Thiazole derivative, its preparation, and antihistaminic agent containing the same | |
| ATE26255T1 (de) | Verfahren zur herstellung von 1,2-diolen. | |
| DE69011677D1 (de) | Verfahren zur herstellung von substituierten ethenen. | |
| ES8703475A1 (es) | Un procedimiento para la preparacion de derivados de 5-cetomilbemicina. | |
| ES8307236A1 (es) | Un procedimiento para la preparacion de ranitidina. | |
| EP0223512A3 (en) | 2-pyridylacetic acid derivative, preparation process thereof and pharmaceutical composition containing the same | |
| GR1000469B (el) | Mεθοδος παρασκευης κινολινοκαρβοξυλικων οξεων. | |
| ES485835A1 (es) | Procedimiento para la preparacion de derivados de acido tienilbenzoico | |
| ES502668A0 (es) | Procedimiento para preparar una solucion hidrocarbonada de un compuesto de alquilsodio | |
| ES8606359A1 (es) | Procedimiento para preparar esteres de cefalosporinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970401 |